Appili Therapeutics Reports Financial and Operational Result

13.02.2024 - FDA approved LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND submission to the FDA Engaging regulatory ... Seite 1

Related Keywords

United States , Canada , Canadian , Don Cilla , Saptalis Pharmaceuticals , Appili Therapeutics Inc , Company Or Appili , Nova Scotia , Chief Executive Officer , Appili Therapeutics Registereda Chart , Ppili Therapeutics Registereda Kurs , Ppili Therapeutics Registereda Aktie ,